Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects will be treated in repeating 4 week cycles.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
274
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Arizona Cancer Center
Tucson, Arizona, United States
University of Southern California Norris Cancer Center
Los Angeles, California, United States
UCLA
Los Angeles, California, United States
St. Francis Memorial Hospital
San Francisco, California, United States
Outpatient Clinic
Santa Monica, California, United States
University of Colorado
Aurora, Colorado, United States
The Harold Lever Regional Cancer Center
Waterbury, Connecticut, United States
Lakeland Regional Cancer Center
Lakeland, Florida, United States
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
Lutheran General
Park Ridge, Illinois, United States
...and 21 more locations